Bispecific Antibodies in the Management of Lymphoma — ASH 2025 Review

Research To Practice | Oncology Videos · Jan 21, 2026 · 1h 1m

Featuring perspectives from Prof Michael Dickinson and Dr Laurie H Sehn, including the following topics:

Introduction (0:00)

Future Treatment of Non-Hodgkin Lymphoma (NHL) (2:24)

Case: A man in his mid 60s with diffuse large B-cell lymphoma (DLBCL) and early relapse on axicabtagene ciloleucel receives glofitamab — Dr Sehn (8:10)

Case: A man in his late 60s with Type 2 diabetes, congestive heart failure and chronic obstructive pulmonary disease receives glofitamab monotherapy after glofitamab with gemcitabine/oxaliplatin for relapsed GCB-type double-hit DLBCL — Matthew Lunning, DO (14:54)…